Hyaluronan production in human rheumatoid fibroblastic synovial lining cells is increased by interleukin 1β but inhibited by transforming growth factor β1

Annals of the Rheumatic Diseases

Volumn 57, Issue 10, 1998, Pages 602-605

  Kawakami, Makoto ^a   Suzuki, Kimihiro ^a   Matsuki, Yasunori ^a   Ishizuka, Toshiaki ^a   Hidaka, Toshihiko ^a   Konishi, Tatsuya ^a   Matsumoto, Mitsuyo ^a   Kataharada, Koji ^a   Nakamura, Haruo ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID; INTERLEUKIN 1BETA; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FIBROBLAST; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIOCYTE;

EID: 0031733163     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.57.10.602     Document Type: Article

References (33)

1. Laurent TC, Fraser JR. Hyaluronan. FASEB J 1992;6;2397-404.
2. Oksala O, Salo T, Tammi R, Hakkinen L, Jalkanen M, Inki P, et al. Expression of proteoglycans and hyaluronan during wound healing. J Histochem Cytochem 1995;43:125-35.
3. Underhill CB, Nguyen HA, Shizari M, Culty M. CD44 positive macrophages take up hyaluronan during lung development. Dev Biol 1993;155:324-36.
4. Bartolazzi A, Peach R, Aruffo A, Stamenkovic I. Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J Exp Med 1994;180:53-66.
5. Swann DA, Radin EL, Nazimiec M, Weisser PA, Curran N, Lewinnek G. Role of hyaluronic acid in joint lubrication. Ann Rheum Dis 1974;33:318-26.
6. Vuorio E, Einola S, Hakkarainen S, Penttinen R. Synthesis of underpolymerized hyaluronic acid by fibroblasts cultured from rheumatoid and non-rheumatoid synovitis. Rheumatol Int 1982;2:97-102.
7. Worrall JG, Bayliss MT, Edwards JC. Morphological localization of hyaluronan in normal and diseased synovium. J Rheumatol 1991;18:1466-72.
8. Kawakami M, Kitani A, Matsukuma S, Hiroi S, Hara M, Ishizuka T, et al. A novel synoviocyte line (RAMAK-1), derived from a patient with rheumatoid arthritis. In Vitro Cell Dev Biol 1998;34:85-87.
9. Kawakami M, Suzuki K, Matsuki Y, Hidaka T, Ishizuka T, Konishi T, et al. Characterization of the newly established human type B synovial lining cell line, RAMAK-1; expression of adhesion molecules and cytokine production. Jpn J Rheumatol (in press).
10. Itano N, Kimata K. Molecular cloning of human hyaluronan synthase. Biochem Biophys Res Commun 1996;222: 816-20.
11. Shyjan AM, Heldin P, Butcher EC, Yoshino T, Briskin MJ. Functional cloning of the cDNA for a human hyaluronan synthase. J Biol Chem 1996;271:2335-99.
12. Spicer AP, McDonald JA. Characterization and molecular evolution of a vertebrate hyaluronan synthase gene family. J Biol Chem 1998;273:1923-32.
13. Meyer KP, Palmer JW. The polysaccharide of the vitreous humor. J Biol Chem 1934;107:629-34.
14. Miller D, O'Connor P, Williams J. Use of Na-hyaluronate during intraocular lens implantation in rabbits. Ophthalmic Surg 1977;8:58.
15. Namiki O, Toyoshima H, Morisaki N. Therapeutic effect of intra-articular injection of high molecular weight hyaluronic acid on osteoarthritis of the knee. Int J Clin Pharmacol Ther Toxicol 1982;20:501-7.
16. Dixon AS, Jacoby RK, Berry H, Hamilton EB. Clinical trial of intra-articular injection of sodium hyaluronate in patients with osteoarthritis of the knee. Curr Med Res Opin 1988;11:205-13.
17. Grecomoro G, Martorana U, Di MC. Intra-articular treatment with sodium hyaluronate in gonarthrosis: a controlled clinical trial versus placebo. Pharmatherapeutica 1987;5:137-41.
18. Peyron JG. Intraarticular hyaluronan injections in the treatment of osteoarthritis: state-of-the-art review. J Rheumatol 1993;20 (suppl 39):10-15.
19. Engstrom-Laurent A, Hallgren R. Circulating hyaluronic acid levels vary with physical activity in healthy subjects and in rheumatoid arthritis patients. Relationship to synovitis mass and morning stiffness. Arthritis Rheum 1987; 30: 1333-8.
20. Pitsillides AA, Worrall JG, Wilkinson LS, Bayliss MT, Edwards JC. Hyaluronan concentration in non-inflamed and rheumatoid synovium. Br J Rheumatol 1994;33:5-10.
21. Kawaguchi Y, Kitani A, Hara M, Harigai M, Hirose T, Suzuki K, et al. Cytokine regulation of prolyl 4-hydroxylase production in skin fibroblast cultures from patients with systemic sclerosis: conribution to collagen synthesis and fibrosis. J Rheumatol 1992;19:1195-201.
22. Haubeck HD, Kock R, Fischer DC, van Leur E, Hoffmeister K, Greiling H. Transforming growth factor beta 1, a major stimulator of hyaluronan synthesis in human synovial lining cells. Arthritis Rheum 1995;38:669-77.
23. Kawakami A, Eguchi K, Matsuoka N, Tsuboi M, Kawabe Y, Aoyagi T, et al. Inhibition of fas antigen-mediated apoptosis of rheumatoid synovial cells in vitro by transforming growth factor β1. Arthritis Rheum 1996;39:1267-76.
24. Suzuki M, Asplund T, Yamashita H, Heldin CH, Heldin P. Stimulation of hyaluronan biosynthesis by platelet-derived growth factor-BB and transforming growth factor-beta 1 involves activation of protein kinase C. Biochem J 1995;307:817-21.
25. Massague J. The transforming growth factor-beta family. Annu Rev Cell Biol 1990;6:597-641.
26. Sporn MB, Roberts AB. Transforming growth factor-beta: recent progress and new challenges. J Cell Biol 1992;119: 1017-21.
27. Kuruvilla AP, Shah R, Hochwald GM, Liggitt HD, Palladino MA, Thorbecke GJ. Protective effect of transforming growth factor β1 on experimental autoimmune disease in mice. Proc Natl Acad Sci USA 1991;88:2918-21.
28. Allen JB, Manthey CL, Hand AR, Ohura K, Ellingsworth L, Wahl SM. Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor beta. J Exp Med 1990;171:231-47.
29. Elford PR, Graeber M, Ohtsu H, Aeberhard M, Legendre B, Wishart WL, et al. Induction of swelling, synovial hyperplasia and cartilage proteoglycan loss upon intra-articular injection of transforming growth factor beta-2 in the rabbit. Cytokine 1992;4;232-8.
30. Brandes ME, Allen JB, Ogawa Y, Wahl SM. Transforming growth factor beta 1 suppresses acute and chronic arthritis in experimental animals. J Clin Invest 1991;87:1108-13.
31. Thorbecke GJ, Shah R, Leu CH, Kuruvilla AP, Hardison AM, Palladino MA. Involvement of endogenous tumor necrosis factor alpha and transforming growth factor beta during induction of collagen type II arthritis in mice. Proc Natl Acad Sci USA 1992;89:7375-9.
32. Gotoh S, Onaya J, Abe M, Miyazaki K, Hamai A, Horie K, et al. Effects of the molecular weight of hyaluronic acid and its action mechanisms on experimental joint pain in rats. Ann Rheum Dis 1993;52:817-22.
33. Aruffo A, Stamenkovic I, Melnick M, Underbill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990;61:1303-13.